Searched for
THYROCARE ACQUISITIONS
PharmEasy fails to raise Rs 1,000 crore equity, breaches covenant on Goldman Sachs loanPharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...01 Jun, 2023, 05.34 PM IST- PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...14 Sep, 2022, 09.28 AM IST
- Watch out for these factors in Thyrocare as closely as you would watch any symptoms!Through strategic acquisitions in the healthcare space, the company seems to be aiming to create “a holistic healthcare ecosystem”. From th...12 Mar, 2022, 12.25 PM IST
- Diagnostic stocks scramble for new growth in India as Covid gains halveSurging healthcare spending and demand for Covid tests led to multifold share-price gains for pathology firms globally during the pandemic.21 Feb, 2022, 10.32 AM IST
- Tata-owned 1mg, PharmEasy go offline for omnichannel presenceTata-owned 1mg is set to open its first physical store in Gurugram next month while rival PharmEasy has started to expand across the offlin...30 Nov, 2021, 06.18 AM IST
- PharmEasy parent API Holdings files papers for Rs 6,250 crore IPOAPI Holdings, the parent of online pharmacy PharmEasy, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for a ₹...11 Nov, 2021, 10.40 AM IST
- Lal PathLabs can fortify its hold if suburban is integrated wellDr Lal PathLabs (LPL), India's largest diagnostics player by revenue and presence, is slated to become bigger with the acquisition of Subur...28 Oct, 2021, 06.42 AM IST
- PharmEasy acquires Aknamed in $180-$190 million stock dealThe acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a...14 Sep, 2021, 08.22 PM IST
- Entry of big firms in healthcare space will benefit users: PharmEasy's Siddharth ShahAPI Holdings' Siddharth Shah on what’s next for Thyrocare after the PharmEasy deal, API’s existing online drug delivery business, and what ...01 Jul, 2021, 06.01 AM IST
- When Davids strike Goliath-sized dealsLast week, the six-year old PharmEasy announced that it was scooping up the 26-year-old Thyrocare. Earlier this month, the three-year-old B...30 Jun, 2021, 07.53 AM IST
- Thyrocare set for fast track with PharmEasyThyrocare is primarily a B2B diagnostic services provider. With PharmEasy’s presence, it will no longer be seen as a conventional diagnosti...30 Jun, 2021, 06.21 AM IST
- Market Movers: Thyrocare tanks on undercooked open offer; oil stocks rallyAPI Holdings, the owner of PharmEasy, will make an open offer to acquire 26 per cent additional stake in the company after buying out the p...28 Jun, 2021, 07.09 PM IST
- PharmEasy buyout puts Thyrocare in a different league: AnalystsThyrocare is making efforts to bolster its brand visibility through the opening of regional and zonal reference laboratories and branded co...28 Jun, 2021, 11.09 AM IST
- ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare dealPharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of whi...28 Jun, 2021, 08.08 AM IST
- PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crorePharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever...26 Jun, 2021, 01.40 PM IST
- Healthcare players slip after debut, recovery unlikely soonCompetition from private equitybacked players also posed a risk to growth.16 Jan, 2019, 10.35 AM IST
- Constellation Alpha to acquire pathology chain Medall HealthcareConstellation was formed as a public platform for acquiring Indian healthcare businesses. Constellation raised $144 million in its initial ...03 Aug, 2018, 12.55 PM IST
Load More
